Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)

Beijing SL Pharmaceutical Revenue

In the year 2025, Beijing SL Pharmaceutical had annual revenue of 623.64M CNY, down -5.57%. Beijing SL Pharmaceutical had revenue of 164.89M in the quarter ending December 31, 2025, with 37.57% growth.

• Revenue: 623.64M
• Revenue Growth: -5.57%
• P/S Ratio: 11.25
• Revenue / Employee: 701.51K
• Employees: 889
• Market Cap: 7.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	623.64M	-36.78M	-5.57%
Dec 31, 2024	660.42M	-357.94M	-35.15%
Dec 31, 2023	1.02B	-31.81M	-3.03%
Jan 1, 2023	1.05B	-164.65M	-13.55%
Jan 1, 2022	1.21B	102.08M	9.17%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error